Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于公司产品纳入《国家医保药品目录》的公告 | 2025-12-07 | Chinese | |
| 关于归还用于暂时补充流动资金的闲置募集资金的公告 | 2025-12-01 | Chinese | |
| 关于盐酸恩沙替尼胶囊上市许可申请获得欧洲药品管理局受理的公告 | 2025-11-28 | Chinese | |
| 关于盐酸恩沙替尼胶囊术后辅助治疗适应症药品注册申请获得受理的公告 | 2025-11-26 | Chinese | |
| 关于与晟斯生物达成战略合作暨签署《商业合作协议》的公告 | 2025-11-02 | Chinese | |
| 关于股东股份质押变动的公告 | 2025-10-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37811438 | 关于公司产品纳入《国家医保药品目录》的公告 | 2025-12-07 | Chinese | ||
| 37811430 | 关于归还用于暂时补充流动资金的闲置募集资金的公告 | 2025-12-01 | Chinese | ||
| 37811402 | 关于盐酸恩沙替尼胶囊上市许可申请获得欧洲药品管理局受理的公告 | 2025-11-28 | Chinese | ||
| 37811385 | 关于盐酸恩沙替尼胶囊术后辅助治疗适应症药品注册申请获得受理的公告 | 2025-11-26 | Chinese | ||
| 37811375 | 关于与晟斯生物达成战略合作暨签署《商业合作协议》的公告 | 2025-11-02 | Chinese | ||
| 37811371 | 关于股东股份质押变动的公告 | 2025-10-30 | Chinese | ||
| 37811357 | 2025年三季度报告 | 2025-10-27 | Chinese | ||
| 37811353 | 关于股东股份质押变动的公告 | 2025-10-27 | Chinese | ||
| 37811341 | 关于向香港联交所递交境外上市股份（H股）发行并上市申请并刊发申请资料的公告 | 2025-09-30 | Chinese | ||
| 37811330 | 国浩律师（杭州）事务所关于贝达药业股份有限公司2025年第一次临时股东大会的法律意见书 | 2025-09-26 | Chinese | ||
| 37811311 | 2025年第一次临时股东大会决议公告 | 2025-09-26 | Chinese | ||
| 37811299 | 第四届董事会第二十七次会议决议公告 | 2025-09-19 | Chinese | ||
| 37811295 | 贝达药业股份有限公司监事会议事规则（草案）（2025年9月） | 2025-09-10 | Chinese | ||
| 37811284 | 贝达药业股份有限公司股东大会议事规则（草案）（2025年9月） | 2025-09-10 | Chinese | ||
| 37811272 | 贝达药业股份有限公司章程（草案）修订对比表 | 2025-09-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.